ERBB2 and breast carcinoma: Therefore, even at lower E:T, CS1-BATs can provide an extended effect against MM cells that can be further enhanced through multiple infusions of BATs to promote a cytotoxic anti-tumor microenvironment over time as was seen with HER2-BATs-treated breast cancer pts (5).